Electroconvulsive therapy-induced cortisol release after dexamethasone in depression

Area of Science:

• Neuroscience
• Endocrinology
• Psychiatry

Background:

• Major depressive disorder is often associated with elevated cortisol levels.
• Dexamethasone is used to suppress baseline cortisol in depressed patients.
• Electroconvulsive therapy (ECT) is a treatment for severe depression.

Purpose of the Study:

• To investigate the effect of ECT on cortisol release in male patients with melancholic depression.
• To determine if cortisol levels change during a course of ECT.
• To compare the impact of unilateral versus bilateral ECT on cortisol release.

Main Methods:

• 12 inpatient male patients with melancholic depression received ECT.
• Dexamethasone was administered to control for elevated baseline cortisol.
• Cortisol levels were measured before and after ECT sessions.
• Statistical analysis, including binomial and t-tests, was performed.

Main Results:

• ECT induced a significant decrease in cortisol release (p = 0.00024).
• Cortisol levels dropped by an average of 55% from the first ECT to 6+ ECTs.
• The decrease in cortisol was significantly larger with unilateral ECT compared to bilateral ECT (p = 0.042).

Conclusions:

• ECT effectively reduces cortisol release in male patients with melancholic depression.
• Unilateral ECT may show a greater reduction in cortisol release over a treatment course compared to bilateral ECT.
• Findings suggest a potential link between ECT's impact on the hypothalamic-pituitary-adrenal axis and its therapeutic effects.